Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations.
about
Genotyping and molecular characterization of hepatitis B virus from human immunodeficiency virus-infected individuals in southern AfricaSafety and efficacy of telbivudine for the treatment of chronic hepatitis BClinical and virological characteristics of hepatitis B or C virus co-infection with HIV in Indonesian patients.Viral dynamics of hepatitis B virus DNA in human immunodeficiency virus-1-hepatitis B virus coinfected individuals: similar effectiveness of lamivudine, tenofovir, or combination therapy.Factors associated with delayed hepatitis B viral suppression on tenofovir among patients coinfected with HBV-HIV in the CNICS cohortVirology and clinical sequelae of drug-resistant HBV in HIV-HBV-coinfected patients on highly active antiretroviral therapy.Is there Emergence of Clinical HBV Resistance Under Long-Term HBV Combination Therapy? A Challenging Case Report.HIV-hepatitis B virus co-infection: epidemiology, pathogenesis, and treatment.Molecular epidemiology of co-infection with hepatitis B virus and human immunodeficiency virus (HIV) among adult patients in Harare, Zimbabwe.Case report: management and HBV sequencing in a patient co-infected with HBV and HIV failing tenofovir.Hepatitis B virus drug resistance to current nucleos(t)ide analogs: Mechanisms and mutation sites.Naturally occurring hepatitis B virus reverse transcriptase mutations related to potential antiviral drug resistance and liver disease progression.
P2860
Q28484102-A29BDA13-4002-4F30-90D2-E2275E7B4AAFQ28972486-82901AD0-40BB-4E7F-86B4-3316C90517E9Q31054551-4478B501-E307-4375-8ED3-C77449C8157BQ37287635-C3E11DB9-0675-483D-9BA6-15B84DBB0B5FQ37694907-E1725739-2C33-4B9A-9E57-8A0C60F88AD4Q37762108-B12294FA-70FA-44CC-B638-7B3E3B65FC2CQ38615613-B313F79C-571B-42B3-93A2-B71A52608D55Q39425755-AF89A289-22A8-41F5-9DD3-762E415230C5Q40599667-82A3AFC5-DBB9-4981-9562-67A38E2A437CQ44937235-0E792216-5CB2-429C-8EB8-7F5C88499952Q45363333-7BB79228-12F9-45A4-8E88-D3ABF376A55FQ55019535-C9C1236C-6A2D-4A76-B787-FB0A8AB84F70
P2860
Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Prolonged use of tenofovir in ...... dine HBV polymerase mutations.
@en
Prolonged use of tenofovir in HIV/hepatitis B virus
@nl
type
label
Prolonged use of tenofovir in ...... dine HBV polymerase mutations.
@en
Prolonged use of tenofovir in HIV/hepatitis B virus
@nl
prefLabel
Prolonged use of tenofovir in ...... dine HBV polymerase mutations.
@en
Prolonged use of tenofovir in HIV/hepatitis B virus
@nl
P2093
P1433
P1476
Prolonged use of tenofovir in ...... udine HBV polymerase mutations
@en
P2093
A Bartholomeusz
J Sasadeusz
L K W Yuen
S A Locarnini
P304
P356
10.1111/J.1468-1293.2008.00675.X
P577
2009-01-28T00:00:00Z